Risks of long-acting beta-agonists in achieving asthma control.
Drazen
Jeffrey M
JM
O'Byrne
Paul M
PM
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018570:Risk Assessment
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents